3522集团新网站(中国)有限公司

Welcome to Linuo Group!HomeBusiness License
  • CN

  • WeChat

  • Mobile Site

  • Search

力诺产业

Shandong Keyuan Pharmaceutical Co., Ltd.

2018.07.25

The company was founded in 2004 and was listed on NEEQ in March 2015. It is dedicated to the research, manufacture, and sales of APIs. It has 21 API approval numbers, two exclusive drugs and 1 new drug of catagory II. Among all products, palonosetron hydrochloride has obtained the accreditation of US FDA, isosorbide mononitrate and gliclazide the accreditation of CEP, metformin HCL the accreditation of PMDA and KFDA and they are sold to European countries, the US, Japan and South Korea.  

 

Baidu
sogou